Pralidoxime Iodide (Phebra) is a medicine containing the active ingredient(s) pralidoxime iodide. On this page you will find out more about Pralidoxime Iodide (Phebra), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: pralidoxime iodide
Information for medicine and pack size:
Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection solution, 20 mL ampoule
Consumer Medicine Information leaflet:
No consumer medicine information leaflet was found for the pack size you selected. It may be unavailable or there may be a technical problem. You should speak to your pharmacist, healthcare professional, or call healthdirect on 1800 022 222 for more information.
What this medicine is for
INDICATIONS AS AT 01 JAN 1991 : Pralidoxime Iodide injection is indicated as an antidote for : The treatment of poisoning due to those pesticides and chemicals of the organophosphate class which have anticholinesterase activity, and the control of overdosage by anticholinesterase drugs used in the treatment of myasthenia gravis.
Table of characteristics
|Visual appearance||Clear, colourless to pale straw coloured solution.|
|Dosage Form||Injection, solution|
|Route of administration||Intravenous|
20mL X 1: Not scheduled. Not considered by committee
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||No information available|
|Life time||2 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.